Know Cancer

or
forgot password
  • cancer clinical trials in alexandria, LA

  • Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lung Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Breast Cancer
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain Tumor, Central Nervous System Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lymphoma
    Radiation Therapy in Treating Young Patients With Gliomas
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain Tumor, Central Nervous System Tumor
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Head and Neck Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Christus Saint Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Kidney Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Neuroblastoma
    Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Prostate Cancer
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Neuroblastoma
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Non-Small Cell Lung Cancer
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lung Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Tulane Cancer Center Office of Clinical Research

    Trial Locations
    Tulane Cancer Center Office of Clinical Research
    Northeast Louisiana Cancer Institute at St. Francis Medical Center
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Lymphoma
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Lymphoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Tissue From Young Patients With Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Cancer
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lymphoma
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Neuroblastoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain and Central Nervous System Tumors
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Prostate Cancer
    S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lung Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Head and Neck Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Christus Saint Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Tulane Cancer Center Office of Clinical Research

    Trial Locations
    Tulane Cancer Center Office of Clinical Research
    CHRISTUS Cabrini Cancer Center
    Colorectal Cancer, Precancerous Condition
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center
    Alexandria, Louisiana 71301
    Adenocarcinoma of the Lung
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    Cabrini Center for Cancer Care
    Alexandria, Louisiana 71301
    Chronic Myelogenous Leukemia in Chronic Phase
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Christus Saint Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Fungal Infection, Leukemia, Neutropenia
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Prostate Cancer